Works matching AU Kahl B

Results: 53

Acute promyelocytic leukaemia and acquired alpha-2-plasmin inhibitor deficiency: a retrospective look at the use of epsilon-aminocaproic acid (Amicar) in 30 patients.

Published in:

2008

By:

Wassenaar T;
Black J;
Kahl B;
Schwartz B;
Longo W;
Mosher D;
Williams E;
Wassenaar, T;
Black, J;
Kahl, B;
Schwartz, B;
Longo, W;
Mosher, D;
Williams, E

Publication type:

journal article

Boronated metalloporphyrins: a novel approach to the diagnosis and treatment of cancer using contrast-enhanced MR imaging and neutron capture therapy.

Published in:

1993

By:

Huang, Leryang R.;
Straubinger, Robert M.;
Kahl, Stephen B.;
Koo, Myoung-Seo;
Alletto, James J.;
Mazurchuk, Richard;
Chau, Robert I.;
Thamer, Sandra L.;
Fiel, Robert J.;
Huang, L R;
Straubinger, R M;
Kahl, S B;
Koo, M S;
Alletto, J J;
Mazurchuk, R;
Chau, R I;
Thamer, S L;
Fiel, R J

Publication type:

journal article

The Hagemeister article reviewed. Current controversies in the management of Hodgkin's lymphoma.

Published in:

2007

By:

Chang J;
Bradley K;
Kahl B

Publication type:

Journal Article

High-resolution chromatin immunoprecipitation (ChIP) sequencing reveals novel binding targets and prognostic role for SOX11 in mantle cell lymphoma.

Published in:

Oncogene, 2015, v. 34, n. 10, p. 1231, doi. 10.1038/onc.2014.44

By:

Kuo, P-Y;
Leshchenko, V V;
Fazzari, M J;
Perumal, D;
Gellen, T;
He, T;
Iqbal, J;
Baumgartner-Wennerholm, S;
Nygren, L;
Zhang, F;
Zhang, W;
Suh, K S;
Goy, A;
Yang, D T;
Chan, W-C;
Kahl, B S;
Verma, A K;
Gascoyne, R D;
Kimby, E;
Sander, B

Publication type:

Article

PHASE II/III STUDY OF R‐MINICHOP ± ORAL AZACITIDINE IN PARTICIPANTS AGE 75 YEARS OR OLDER WITH DIFFUSE LARGE B CELL AND RELATED LYMPHOMAS.

Published in:

Hematological Oncology, 2023, v. 41, p. 848, doi. 10.1002/hon.3166_OT27

By:

Brem, E. A.;
Li, H.;
Beaven, A. W.;
Caimi, P.;
Cerchietti, L.;
Olin, R. L.;
Henry, N. L.;
Dilon, H.;
Little, R. F.;
Leblanc, M. L.;
Kahl, B.;
Leonard, J. P.;
Friedberg, J. W.;
Smith, S. M.

Publication type:

Article

SWOG 2114: A RANDOMIZED PHASE II TRIAL OF CONSOLIDATION THERAPY FOLLOWING CD19 CAR T‐CELL TREATMENT FOR RELAPSED/REFRACTORY LARGE B‐CELL OR GRADE IIIB FOLLICULAR LYMPHOMA.

Published in:

Hematological Oncology, 2023, v. 41, p. 839, doi. 10.1002/hon.3166_OT19

By:

Hess, B.;
Li, H.;
Hossain, N.;
Beylergil, V.;
Sauter, C.;
Hamadani, M.;
Svoboda, J.;
Major, A.;
Kahl, B.;
Leonard, J. P;
Smith, S.;
LeBlanc, M.;
Stiff, P.;
Friedberg, J. W

Publication type:

Article

TRANSCEND FL: PHASE 2 STUDY RESULTS OF LISOCABTAGENE MARALEUCEL (LISO‐CEL) IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY (R/R) FOLLICULAR LYMPHOMA (FL).

Published in:

Hematological Oncology, 2023, v. 41, p. 877, doi. 10.1002/hon.3196_LBA4

By:

Morschhauser, F.;
Dahiya, S.;
Palomba, M. L.;
Garcia‐Sancho, A. M.;
Ortega, J. L. Reguera;
Kuruvilla, J.;
Jager, U.;
Cartron, G.;
Izutsu, K.;
Dreyling, M.;
Kahl, B.;
Ghesquieres, H.;
Ardeshna, K.;
Goto, H.;
Barbui, A. M.;
Abramson, J. S.;
Borchmann, P.;
Fleury, I.;
Mielke, S.;
Farazi, T.

Publication type:

Article

Zanubrutinib safety/tolerability profile and comparison with ibrutinib profile in B‐cell malignancies: Post hoc analysis of a large clinical trial safety database.

Published in:

Hematological Oncology, 2023, v. 41, p. 459, doi. 10.1002/hon.3164_339

By:

Brown, J. R.;
Eichorst, B.;
Ghia, P.;
Jurczak, W.;
Kahl, B. S.;
Lamanna, N.;
Robak, T.;
Shadman, M.;
Tam, C. S.;
Qiu, L.;
Cohen, A.;
Zhang, M.;
Salmi, T.;
Paik, J.;
Wang, L.;
Zhang, J.;
Ma, H.;
Tedeschi, A.

Publication type:

Article

Venetoclax combined with R‐ICE (VICER) for second line treatment of diffuse large B cell lymphoma refractory or relapsed after initial chemoimmunotherapy.

Published in:

Hematological Oncology, 2023, v. 41, p. 436, doi. 10.1002/hon.3164_321

By:

Caimi, P. F.;
Cashen, A.;
Gallogly, M.;
Winter, A.;
Boughan, K.;
Ghobadi, A.;
Jagadeesh, D.;
Cooper, B.;
Mehta‐Shah, N.;
Dean, R.;
Metheny, L.;
Pohlman, B.;
Bartlett, N. L.;
de Lima, M.;
Kahl, B. S.;
Hill, B. T.

Publication type:

Article

Defining Primary Refractory Diffuse Large B‐cell Lymphoma (DLBCL) Based on Survival Outcomes.

Published in:

Hematological Oncology, 2023, v. 41, p. 430, doi. 10.1002/hon.3164_317

By:

Bock, A. M.;
Mwangi, R.;
Wang, Y.;
Khurana, A.;
Maurer, M. J.;
Ayers, A.;
Kahl, B.;
Martin, P.;
Cohen, J.;
Casulo, C.;
Lossos, I.;
Farooq, U.;
Ayyappan, S.;
Reicks, T.;
Habermann, T. M.;
Flowers, C. R.;
Cerhan, J. R.;
Nastoupil, L. J.;
Nowakowski, G. S.

Publication type:

Article

Overall survival in classic Hodgkin lymphoma pts who progress after autologous stem cell transplant in the era of novel agents.

Published in:

Hematological Oncology, 2023, v. 41, p. 366, doi. 10.1002/hon.3164_264

By:

Desai, S. H.;
Spinner, M.;
Evens, A. M.;
Bachanova, V.;
Goyal, G.;
Kahl, B.;
Dorritie, K.;
Azzi, J.;
Kenkre, V. P.;
Arai, S.;
Chang, C.;
Fusco, B.;
Sumransub, N.;
Hatic, H.;
Saba, R.;
Ibrahim, U.;
Harris, E. I.;
Ansell, S. M.;
Shah, H.;
Wagner‐Johnston, N.

Publication type:

Article

Efficacy of brentuximab consolidation by metabolic response in an international real‐world cohort of classic Hodgkin lymphoma at high risk for progression after ASCT.

Published in:

Hematological Oncology, 2023, v. 41, p. 361, doi. 10.1002/hon.3164_260

By:

Desai, S. H.;
Smith, A.;
Spinner, M.;
Sykorova, A.;
Bachanova, V.;
Evens, A. M.;
Goyal, G.;
Kahl, B.;
Dorritie, K.;
Azzi, J.;
Kenkre, V. P.;
Chang, C.;
Michalka, J.;
Fusco, B.;
Sumransub, N.;
Hatic, H.;
Saba, R.;
Ibrahim, U.;
Harris, E. I.;
Shah, H.

Publication type:

Article

ZANUBRUTINIB (ZANU) VERSUS BENDAMUSTINE + RITUXIMAB (BR) IN PATIENTS (PTS) WITH TREATMENT‐NAïVE (TN) CLL/SLL: EXTENDED FOLLOW‐UP OF THE SEQUOIA STUDY.

Published in:

Hematological Oncology, 2023, v. 41, p. 235, doi. 10.1002/hon.3163_154

By:

Shadman, M.;
Munir, T.;
Roback, T.;
Brown, J. R.;
Kahl, B. S.;
Ghia, P.;
Giannopoulos, K.;
Šimkovič, M.;
Österborg, A.;
Laurenti, L.;
Walker, P.;
Opat, S.;
Ciepluch, H.;
Greil, R.;
Hanna, M.;
Tani, M.;
Trněný, M.;
Brander, D.;
Flinn, I. W.;
Grosicki, S.

Publication type:

Article

LONG‐TERM RESPONSES WITH LONCASTUXIMAB TESIRINE: UPDATED RESULTS FROM LOTIS‐2, THE PIVOTAL PHASE 2 STUDY IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA.

Published in:

Hematological Oncology, 2023, v. 41, p. 209, doi. 10.1002/hon.3163_137

By:

Caimi, P. F;
Ai, W. Z;
Alderuccio, J. P.;
Ardeshna, K. M;
Hamadani, M.;
Hess, B.;
Kahl, B. S;
Radford, J.;
Solh, M.;
Stathis, A.;
Zinzani, P. L.;
Wang, Y.;
Qin, Y.;
Wang, L.;
Xu, C.;
Carlo‐Stella, C.

Publication type:

Article

CLINICAL OUTCOMES IN PATIENTS RELAPSED/REFRACTORY AFTER ≥ 2 PRIOR LINES OF THERAPY FOR FOLLICULAR LYMPHOMA: A SYSTEMATIC LITERATURE REVIEW AND META‐ANALYSIS.

Published in:

Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.28_2881

By:

Kanters, S;
Kahl, B;
Wiesinger, A;
Gurung, B;
Limbrick‐Oldfield, E. H;
Sudhindra, A;
Thornton Snider, J;
Patel, A. R

Publication type:

Article

ESCALADE: A PHASE 3 STUDY OF ACALABRUTINIB IN COMBINATION WITH R‐CHOP FOR PATIENTS ≤65Y WITH UNTREATED NON‐GERMINAL CENTER B‐CELL–LIKE DIFFUSE LARGE B‐CELL LYMPHOMA.

Published in:

Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.164_2880

By:

Sehn, L. H.;
Kahl, B.;
Matasar, M.;
Lentz, G.;
Izutsu, K.;
Zhao, W.;
Tao, L.;
Calvo, R.;
Zinzani, P. L.

Publication type:

Article

EXTENDED FOLLOW‐UP OF A PHASE I TRIAL OF IPILIMUMAB, NIVOLUMAB AND BRENTUXIMAB VEDOTIN IN RELAPSED HODGKIN LYMPHOMA: A TRIAL OF THE ECOG‐ACRIN RESEARCH GROUP (E4412).

Published in:

Hematological Oncology, 2019, v. 37, p. 123, doi. 10.1002/hon.83_2629

By:

Diefenbach, C.S.;
Hong, F.;
Ambinder, R.;
Cohen, J.;
Robertson, M.;
David, K.;
Advani, R.;
Fenske, T.;
Barta, S.;
Palmisano, N.;
Svoboda, J.;
Morgan, D.;
Karmali, R.;
Kahl, B.;
Ansell, S.

Publication type:

Article

ANALYSIS OF EFFICACY AND SAFETY OF LONCASTUXIMAB TESIRINE (ADCT‐402) BY DEMOGRAPHIC AND CLINICAL CHARACTERISTICS IN RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA.

Published in:

Hematological Oncology, 2019, v. 37, p. 93, doi. 10.1002/hon.60_2629

By:

Radford, J.;
Kahl, B.;
Hamadani, M.;
Carlo‐Stella, C.;
O'Connor, O.A.;
Ardeshna, K.M.;
Feingold, J.;
He, S.;
Reid, E.;
Solh, M.;
Chung, K.;
Heffner, L.;
Ungar, D.;
Caimi, P.

Publication type:

Article

A PHASE 3 STUDY OF ACALABRUTINIB PLUS BENDAMUSTINE AND RITUXIMAB IN ELDERLY (AGED ≥65 Years) TREATMENT‐NAIVE PATIENTS WITH MANTLE CELL LYMPHOMA.

Published in:

Hematological Oncology, 2019, v. 37, p. 554, doi. 10.1002/hon.2632

By:

Wang, M.;
Belada, D.;
Cheah, C.;
Chu, M.P.;
Dreyling, M.;
Flinn, I.;
Fogliatto, L.;
Goy, A.;
Inwards, D.;
Jurczak, W.;
Mayer, J.;
Re, F.;
Robak, T.;
Spurgeon, S.;
Yoon, S.S.;
Zinzani, P.L.;
Yin, M.;
Chen, T.;
Kahl, B.

Publication type:

Article

POLATUZUMAB VEDOTIN (POLA) + OBINUTUZUMAB (G) + LENALIDOMIDE (LEN) IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY (R/R) FOLLICULAR LYMPHOMA (FL): PHASE IB/II INTERIM ANALYSIS.

Published in:

Hematological Oncology, 2019, v. 37, p. 175, doi. 10.1002/hon.132_2629

By:

Diefenbach, C.;
Kahl, B.;
Banerjee, L.;
McMillan, A.;
Ramchandren, R.;
Miall, F.;
Briones, J.;
Cordoba, R.;
Gonzalez‐Barca, E.;
Panizo, C.;
Hirata, J.;
Chang, N.;
Musick, L.;
Abrisqueta, P.

Publication type:

Article

EXTENDED FOLLOW‐UP OF A PHASE I TRIAL OF IPILIMUMAB, NIVOLUMAB AND BRENTUXIMAB VEDOTIN IN RELAPSED HODGKIN LYMPHOMA: A TRIAL OF THE ECOG‐ACRIN RESEARCH GROUP (E4412).

Published in:

Hematological Oncology, 2019, v. 37, p. 123, doi. 10.1002/hon.83_2629

By:

Diefenbach, C.S.;
Hong, F.;
Ambinder, R.;
Cohen, J.;
Robertson, M.;
David, K.;
Advani, R.;
Fenske, T.;
Barta, S.;
Palmisano, N.;
Svoboda, J.;
Morgan, D.;
Karmali, R.;
Kahl, B.;
Ansell, S.

Publication type:

Article

ANALYSIS OF EFFICACY AND SAFETY OF LONCASTUXIMAB TESIRINE (ADCT‐402) BY DEMOGRAPHIC AND CLINICAL CHARACTERISTICS IN RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA.

Published in:

Hematological Oncology, 2019, v. 37, p. 93, doi. 10.1002/hon.60_2629

By:

Radford, J.;
Kahl, B.;
Hamadani, M.;
Carlo‐Stella, C.;
O'Connor, O.A.;
Ardeshna, K.M.;
Feingold, J.;
He, S.;
Reid, E.;
Solh, M.;
Chung, K.;
Heffner, L.;
Ungar, D.;
Caimi, P.

Publication type:

Article

A PHASE 3 STUDY OF ACALABRUTINIB PLUS BENDAMUSTINE AND RITUXIMAB IN ELDERLY (AGED ≥65 Years) TREATMENT‐NAIVE PATIENTS WITH MANTLE CELL LYMPHOMA.

Published in:

Hematological Oncology, 2019, v. 37, p. 554, doi. 10.1002/hon.2632

By:

Wang, M.;
Belada, D.;
Cheah, C.;
Chu, M.P.;
Dreyling, M.;
Flinn, I.;
Fogliatto, L.;
Goy, A.;
Inwards, D.;
Jurczak, W.;
Mayer, J.;
Re, F.;
Robak, T.;
Spurgeon, S.;
Yoon, S.S.;
Zinzani, P.L.;
Yin, M.;
Chen, T.;
Kahl, B.

Publication type:

Article

POLATUZUMAB VEDOTIN (POLA) + OBINUTUZUMAB (G) + LENALIDOMIDE (LEN) IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY (R/R) FOLLICULAR LYMPHOMA (FL): PHASE IB/II INTERIM ANALYSIS.

Published in:

Hematological Oncology, 2019, v. 37, p. 175, doi. 10.1002/hon.132_2629

By:

Diefenbach, C.;
Kahl, B.;
Banerjee, L.;
McMillan, A.;
Ramchandren, R.;
Miall, F.;
Briones, J.;
Cordoba, R.;
Gonzalez‐Barca, E.;
Panizo, C.;
Hirata, J.;
Chang, N.;
Musick, L.;
Abrisqueta, P.

Publication type:

Article

SAFETY AND EFFICACY OF COMBINATION OF BRENTUXIMAB VEDOTIN AND NIVOLUMAB IN RELAPSED / REFRACTORY HODGKIN LYMPHOMA: a TRIAL OF THE ECOG-ACRIN CANCER RESEARCH GROUP (E4412).

Published in:

Hematological Oncology, 2017, v. 35, p. 84, doi. 10.1002/hon.2437_72

By:

Diefenbach, C.S.;
Hong, F.;
David, K.;
Cohen, J.;
Roberston, M.;
Advani, R.;
Palmisano, N.;
Ambinder, R.;
Kahl, B.;
Ansell, S.

Publication type:

Article

RISK-ADAPTED THERAPY IN ADULTS WITH BURKITT LYMPHOMA: UPDATED RESULTS OF a MULTICENTER PROSPECTIVE PHASE II STUDY OF DA-EPOCH-R.

Published in:

Hematological Oncology, 2017, v. 35, p. 133, doi. 10.1002/hon.2437_122

By:

Dunleavy, K.;
Roschewski, M.;
Abramson, J.S.;
Link, B.;
Parekh, S.;
Jagadeesh, D.;
Bierman, P.;
Watson, P.R.;
Peace, D.;
Hanna, W.;
Powell, B.;
Melani, C.;
Lucas, A.;
Steinberg, S.M.;
Kahl, B.;
Friedberg, J.W.;
Little, R.F.;
Bartlett, N.L.;
Fanale, M.A.;
Noy, A.

Publication type:

Article

FIRST CLINICAL RESULTS OF ADCT-402, A NOVEL PYRROLOBENZODIAZEPINE-BASED ANTIBODY DRUG CONJUGATE (ADC), IN RELAPSED/REFRACTORY B-CELL LINEAGE NHL.

Published in:

Hematological Oncology, 2017, v. 35, p. 49, doi. 10.1002/hon.2437_33

By:

Kahl, B.;
Hamadani, M.;
Caimi, P.F.;
Reid, E.G.;
Havenith, K.;
He, S.;
Feingold, J.M.;
O'Connor, O.A.

Publication type:

Article

Acute promyelocytic leukaemia and acquired α-2-plasmin inhibitor deficiency: a retrospective look at the use of epsilon-aminocaproic acid (Amicar) in 30 patients.

Published in:

Hematological Oncology, 2008, v. 26, n. 4, p. 241, doi. 10.1002/hon.867

By:

Wassenaar, T.;
Black, J.;
Kahl, B.;
Schwartz, B.;
Longo, W.;
Mosher, D.;
Williams, E.

Publication type:

Article

Prevalence and characterization of azole-resistant Aspergillus fumigatus in patients with cystic fibrosis: a prospective multicentre study in Germany.

Published in:

2018

By:

Seufert, R;
Sedlacek, L;
Kahl, B;
Hogardt, M;
Hamprecht, A;
Haase, G;
Gunzer, F;
Haas, A;
Grauling-Halama, S;
MacKenzie, C R;
Essig, A;
Stehling, F;
Sutharsan, S;
Dittmer, S;
Killengray, D;
Schmidt, D;
Eskandarian, N;
Steinmann, E;
Buer, J;
Hagen, F

Publication type:

journal article

Is high-resolution ultrasonography suitable for the detection of temporomandibular joint involvement in children with juvenile idiopathic arthritis?

Published in:

Dentomaxillofacial Radiology, 2013, v. 42, n. 3, p. 1, doi. 10.1259/dmfr.20110379

By:

Assaf, A. T.;
Kahl-Nieke, B.;
Feddersen, J.;
Habermann, C. R.

Publication type:

Article

Dentomaxillofacial imaging in Proteus syndrome.

Published in:

Dentomaxillofacial Radiology, 2005, v. 34, n. 3, p. 251, doi. 10.1259/dmfr/22554007

By:

Korbmacher, H.;
Tietke, M.;
Rother, U.;
Kahl-Nieke, B.

Publication type:

Article

Associations between orthopaedic disturbances and unilateral crossbite in children with asymmetry of the upper cervical spine.

Published in:

European Journal of Orthodontics, 2007, v. 29, n. 1, p. 100, doi. 10.1093/ejo/cjl066

By:

Korbmacher, Heike;
Koch, L.;
Eggers-Stroeder, G.;
Kahl-Nieke, B.

Publication type:

Article

Evaluation of an antimicrobial and fluoride-releasing self-etching primer on the shear bond strength of orthodontic brackets.

Published in:

European Journal of Orthodontics, 2006, v. 28, n. 5, p. 457, doi. 10.1093/ejo/cjl013

By:

Korbmacher, H.;
Huck, L.;
Adam, T.;
Kahl-Nieke, B.

Publication type:

Article

Infectious Mononucleosis Progressing to Fatal Malignant Lymphoma: A Case Report and Review of the Literature.

Published in:

Leukemia & Lymphoma, 2003, v. 44, n. 7, p. 1215, doi. 10.1080/1042819031000079221

By:

Kobbervig, C.;
Norback, D.;
Kahl, B.

Publication type:

Article

Cephalometric Evaluation of Children with Down Syndrome After Early Intervention with the Stimulating Plate.

Published in:

Special Care in Dentistry, 2005, v. 25, n. 5, p. 253, doi. 10.1111/j.1754-4505.2005.tb01658.x

By:

Korbmacher, Heike;
Moeller, H. C.;
Klocke, A.;
Limbrock, J.;
Kahl-Nieke, B.

Publication type:

Article

Orthodontic springs and auxiliary appliances: assessment of magnetic field interactions associated with 1.5 T and 3 T magnetic resonance systems.

Published in:

2007

By:

Kemper, J.;
Priest, A. N.;
Schulze, D.;
Kahl-Nieke, B.;
Adam, G.;
Klocke, A.

Publication type:

journal article

A novel preparative regimen for autologous transplant in non-Hodgkin's lymphoma: long-term experience with etoposide and thiotepa.

Published in:

Bone Marrow Transplantation, 2004, v. 33, n. 1, p. 19, doi. 10.1038/sj.bmt.1704312

By:

McCoy, A. G.;
Smith, E. P.;
Atkinson, M. E.;
Baranski, B.;
Kahl, B. S.;
Juckett, M.;
Mitchell, T.;
Gangnon, R.;
Longo, W. L.

Publication type:

Article

Homepages of German dental schools - a target group-oriented evaluation.

Published in:

European Journal of Dental Education, 2014, v. 18, n. 3, p. 128, doi. 10.1111/eje.12067

By:

Wehlers, A.;
Schäfer, I.;
Sehner, S.;
Kahl‐Nieke, B.;
Kuhnigk, O.

Publication type:

Article

„Zahnmedizin der Zukunft".

Published in:

2023

By:

Kahl-Nieke, B.;
Guse, A.;
Koch-Gromus, U.

Publication type:

Editorial

Response to 'In vivo attenuation and genetic evolution of a ST247-SCCmecI MRSA clone after 13 years of pathogenic bronchopulmonary colonization in a patient with cystic fibrosis: implications of the innate immune response'.

Published in:

Mucosal Immunology (1933-0219), 2015, v. 8, n. 3, p. 696, doi. 10.1038/mi.2015.9

By:

Kriegeskorte, A;
Block, D;
Kahl, B C

Publication type:

Article

Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: a report from the International DLBCL Rituximab-CHOP Consortium Program Study

Published in:

Leukemia (08876924), 2014, v. 28, n. 4, p. 980, doi. 10.1038/leu.2014.24

By:

Visco, C;
Li, Y;
Xu-Monette, Z Y;
Miranda, R N;
Green, T M;
Tzankov, A;
Wen, W;
Liu, W-m;
Kahl, B S;
d'Amore, E S G;
Montes-Moreno, S;
Dybkær, K;
Chiu, A;
Tam, W;
Orazi, A;
Zu, Y;
Bhagat, G;
Winter, J N;
Wang, H-Y;
O'Neill, S

Publication type:

Article

Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: a report from the International DLBCL Rituximab-CHOP Consortium Program Study

Published in:

Leukemia (08876924), 2012, v. 26, n. 9, p. 2103, doi. 10.1038/leu.2012.83

By:

Visco, C;
Li, Y;
Xu-Monette, Z Y;
Miranda, R N;
Green, T M;
Tzankov, A;
Wen, W;
Liu, W-m;
Kahl, B S;
d'Amore, E S G;
Montes-Moreno, S;
Dybkær, K;
Chiu, A;
Tam, W;
Orazi, A;
Zu, Y;
Bhagat, G;
Winter, J N;
Wang, H-Y;
O'Neill, S

Publication type:

Article

Linking agricultural diversification practices, soil arthropod communities and soil health.

Published in:

Journal of Applied Ecology, 2023, v. 60, n. 9, p. 1952, doi. 10.1111/1365-2664.14453

By:

Elmquist, Dane C.;
Kahl, Kendall B.;
Johnson‐Maynard, Jodi L.;
Eigenbrode, Sanford D.

Publication type:

Article

Toxicology of a Boronated Porphyrin in Dogs.

Published in:

Photochemistry & Photobiology, 1999, v. 69, n. 5, p. 587, doi. 10.1111/j.1751-1097.1999.tb03332.x

By:

Tibbitts, Jay;
Fike, John R.;
Lamborn, Kathleen R.;
Bollen, Andrew W.;
Kahl, Stephen B.

Publication type:

Article

Photophysics and Intracellular Distribution of a Boronated Porphyrin Phototherapeutic Agent.

Published in:

Photochemistry & Photobiology, 1996, v. 64, n. 6, p. 975, doi. 10.1111/j.1751-1097.1996.tb01864.x

By:

Spizzirri, Paul G.;
Hill, John S.;
Kahl, Stephen B.;
Ghiggino, Kenneth P.

Publication type:

Article

Dose-intense and dose-dense regimens in Hodgkin lymphoma and aggressive non-Hodgkin lymphoma.

Published in:

2007

By:

Kahl B

Publication type:

Journal Article

Dose-intense and dose-dense regimens in Hodgkin lymphoma and aggressive non-Hodgkin lymphoma.

Published in:

2007

By:

Kahl B

Publication type:

Journal Article

Promotes Cementum and Alveolar Bone Growth in a Time-Dependent Manner.

Published in:

2021

By:

Nottmeier, C.;
Liao, N.;
Simon, A.;
Decker, M.G.;
Luther, J.;
Schweizer, M.;
Yorgan, T.;
Kaucka, M.;
Bockamp, E.;
Kahl-Nieke, B.;
Amling, M.;
Schinke, T.;
Petersen, J.;
Koehne, T.

Publication type:

journal article

Rsk2, the Kinase Mutated in Coffin-Lowry Syndrome, Controls Cementum Formation.

Published in:

2016

By:

Koehne, T.;
Jeschke, A.;
Petermann, F.;
Seitz, S.;
Neven, M.;
Peters, S.;
Luther, J.;
Schweizer, M.;
Schinke, T.;
Kahl-Nieke, B.;
Amling, M.;
David, J.-P.

Publication type:

journal article

In Vitro Bond Strength Values: Meaningful or Confusing?

Published in:

2005

By:

Klocke, Arndt;
Kahl-Nieke, B.

Publication type:

Proceeding